Evaluation of Thyroid Cancer Risk After Laryngeal and Nasopharyngeal Radiotherapy

Simple item page
AuthorHamid Ghaznavien
Issued Date2020-12-31en
AbstractBackground: Nasopharyngeal carcinoma is an uncommon head and neck cancer, which is commonly seen in young people aged from 15 to 25 years. Laryngeal cancer, on the other hand, is the second most common cancer among head and neck cancers. The primary treatment for patients with these carcinomas is radiotherapy. Objectives: This study aimed at estimation of thyroid cancer risk, as an organ at risk after laryngeal and nasopharyngeal radiotherapy Methods: with permission from the author, data related to thyroid dose of 20 patients who underwent radiotherapy of laryngeal and nasopharynx cancer in Salmanian et al. paper were used, and using the BEIR VII model, we calculated thyroid cancer risk. Results: lifetime attributable risk (LAR) of thyroid increased up to 2.7% in the treatment of nasopharyngeal cancer and up to 1.8% in the treatment of laryngeal cancer. The highest LAR values belonged to the treatment of nasopharyngeal cancer. Conclusions: radiotherapy for nasopharyngeal and laryngeal cancers considerably increased the risk of thyroid cancer in patients undergoing radiotherapy; such that the risk increased by more than 2.5% at younger ages. It is recommended to use an advanced treatment technique to reduce thyroid cancer risk and perform follow-ups annually in terms of the status of the thyroid gland and its changes.en
DOIhttps://doi.org/10.5812/rro.111991en
KeywordLaryngeal and Nasopharyngeal Cancersen
KeywordRadiotherapyen
KeywordThyroid Cancer Risken
KeywordBEIR VII Modelen
PublisherBrieflandsen
TitleEvaluation of Thyroid Cancer Risk After Laryngeal and Nasopharyngeal Radiotherapyen
TypeResearch Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
rro-7-1-111991.pdf
Size:
368.54 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF
Download

Collections

Reports of Radiotherapy and Oncology